ExpreS2ion appoints CBO and IR partner

ExpreS2ion Biotechnologies ApS (“ExpreS2ion") has appointed Bent U. Frandsen, currently VP of Business Development, as Chief Business Officer (CBO). He will manage a proactive effort to substantially increase the customer base in the Company’s vaccine development and production services segment. Furthermore, ExpreS2ion appoints Honeybadger as non-exclusive IR partner on the Swedish market.The appointment of Bent U. Frandsen as CBO follows the strengthening of the Company’s offer to provide complete services in vaccine development and GMP production to early clinical trials based on its